At this year's ASCB Minisyposium, 10 speakers discussed how cellular metabolism contributes to different cellular functions. Although we know most of the components of cellular metabolic pathways, our understanding on how these pathways are rewired in different environmental and disease contexts has been limited. Talks in this session focused on several aspects of cellular metabolism, ranging from signaling to mitochondrial metabolism to nutrient sensing and metabolic stress.

Mitochondria are central players in cellular metabolism. The mitochondrial matrix houses key metabolic reactions that are in part regulated by ion and substrate availability. **Yasemin Sancak** (University of Washington) presented her group's work on regulation of the mitochondrial calcium uniporter MCU, which plays a critical role in fine-tuning the activity of the tricarboxylic acid cycle. They identified a small region in MCU that specifically interacts with its regulator protein EMRE, and they propose that this interaction is important for the function of the channel. The mitochondrial phosphate carrier (PiC) is another important ion carrier regulating mitochondrial metabolism. **Jennifer Kwong** (Emory University) showed that heart-specific deletion of PiC in mice results in global posttranslational changes in mitochondrial proteins and altered mitochondrial metabolic fluxes, indicating that these changes are a metabolic signature of energy dysfunction. In general, metabolic parameters are also known to change in response to diet, exercise, and diseases; however, molecular tools to alter these parameters to study their role are lacking. **Denis Titov** (University of California, Berkeley) shared his group's work on developing new molecular tools to manipulate several metabolic parameters, including cellular NAD/NADH and NADP/NADPH ratios. Other cellular metabolic parameters, including the availability of amino acids, lipids, and growth factors, are closely monitored to ensure homeostasis. **Roberto Zoncu** (University of California, Berkeley) presented his group's work on developing new in vitro assays and chemical tools to selectively inhibit mTORC1, a kinase that is central to nutrient sensing and the regulation of cellular growth. Their findings have important implications for many diseases that involve activation of the mTORC1 signaling pathway.

It has been well established that cancer cells display unique metabolic features that are not shared by their untransformed counterparts. These changes are partly dictated by oncogenic alterations. **Cosimo Commisso** (Sanford Burnham Prebys) presented his findings on the role of macropinocytosis, a type of nutrient scavenging pathway that supports the growth of KRAS mutant pancreas tumors under nutrient-poor conditions. His group found that glutamine deprivation induces macropinocytosis in an EGFR-dependent manner through activation of Pak1. Metabolic changes in cancer cells may also be exploited therapeutically. **Kivanc Birsoy** (Rockefeller University) identified a rare lymphoma (anaplastic large cell lymphoma) that has lost the ability to synthesize cholesterol. These cancers are highly sensitive to lipoprotein depletion and accumulate squalene, a poorly studied metabolite with anti-ferrototic features. **Jeff Peterson** (Fox Chase Cancer Center) presented his group's findings on a new type of polyunsaturated fatty acids that can selectively trigger ferroptosis in triple-negative breast cancers. Interestingly, feeding mice with natural plant oils rich in conjugated PUFAs may inhibit tumor growth. **Alex Muir** from Matt Vander Heiden's group at the Massachusetts Institute of Technology focused on whether cellular metabolism impacts cancer cell states. He identified that mesenchymal cells display strong dependence for cysteine to maintain cellular glutathione levels. He proposed that this could be targeted for therapy by inhibiting glutamine metabolism.

**Rupali Ugrankar** from Mike Henne's lab (UT Southwestern) discussed how cells organize fat stores for efficient mobilization during nutrient stress. His group identified Snazarus (Snz) as regulator of the distinct peripheral lipid droplet subpopulation in *Drosophila*. Finally, **Judith Ochrietor** (University of North Florida) presented her findings on the effects of lipopolysaccharide (LPS) on metabolism. Contrary to her group's expectations, they found that in response to LPS, Monocarboxylate Transporter 1 (MCT1) expression decreased, suggesting a shift of resources toward induction of the immune response.
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